HeartFlow announced today that the American Medical Association (AMA) transitioned reimbursement codes for its coronary artery disease assessment.
The AMA changed the non-invasive, AI-based FFRCT treatment to a Category I Current Procedural Terminology (CPT) code. It went into effect on Jan. 1, 2024. Mountain View, California-based HeartFlow says the new code supports FFRCT as the standard of care in assessing patients with suspected CAD.
FFRCT Analysis and coronary computed tomography angiography (CCTA), provide an alternative to traditional ischemia testing methods. These methods include stress EKG, stress ECG, SPECT, PET and more. According to HeartFlow, these methods can result in false negatives 20%-30% of the time.
HeartFlow’s method non-invasively diagnoses CAD and offers guidance on subsequent treatment decisions. The AI-powered technology provides insights into each patient’s condition with a patient-specific model of the heart’s blood flow. It …